Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression

Cancer Letters

Volumn 272, Issue 1, 2008, Pages 102-109

  Zheng, Li Hua ^a   Bao, Yong Li ^a   Wu, Yin ^a   Yu, Chun Lei ^a   Meng, XiangYing ^a   Li, Yu Xin ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Cantharidin; Multi drug resistance; P glycoprotein

Indexed keywords

ASIATICOSIDE; AURANTIAMARIN; AURANTIIN; CANTHARIDIN; CHRYSOPHANIC ACID; CINOBUFAGIN; CORDYCEPIN; CURCUMIN; DAPHNETIN; DOXORUBICIN; ESCIN; EUPHOL; FLUOROURACIL; GLYCOPROTEIN P; HUPERZINE A; ICARIIN; ISOALANTOLACTONE; ISORHAMNETIN; MAGNOLOL; PACLITAXEL; PENTOSALEN; PIPERINE; RUBIMAILLIN; SCUTELLARIN; SOYASAPONIN I; SUCCINIC ACID; SYRINGIN; TECTORIGENIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; DRUG SCREENING; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION;

CANTHARIDIN; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; KIDNEY; LIVER NEOPLASMS; P-GLYCOPROTEIN; RNA, MESSENGER; RNA, NEOPLASM;

ANIMALIA;

EID: 54049144205     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.06.029     Document Type: Article

References (28)

1. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. J. Nat. Rev. Cancer 2 (2002) 48-58
2. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., and Deeley R.G. Overexpression of a transporter gene in a multidrug-resistance human lung cancer cell line. Science 258 (1992) 1650-1654
3. Kruh G.D., and Belinsky M.G. The MRP family of drug efflux pumps. Oncogene 22 (2003) 7537-7552
4. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y.M., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. PNAS 95 (1998) 15665-15670
5. Miyake K., Mickley L., Litman T., Zhan Z.R., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., and Bates S.E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59 (1999) 8-13
6. Doyle L.A., and Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 (2003) 7340-7358
7. Kitazono M., Sumizawa T., Takebayashi Y., Chen Z.S., Furukawa T., Nagayama S., Tani A., Takao S., Aikou T., and Akiyama S.I. Multidrug resistance and the lung resistance-related proteinin human colon carcinoma SW-620 cells. J. Natl. Cancer Inst. 91 (1999) 1647-1653
8. Desoize B., and Jardillier J. Multicellular resistance: a paradigm for clinical resistance?. Crit. Rev. Oncol. Hematol. 36 (2000) 193-207
9. Ambudkar S., Kimchi-Sarfaty C., Sauna Z.E., and Gottesman M.M. P-glycoprotein: from genomics to mechanism. Oncogene 22 (2003) 7468-7485
10. Fojo T., and Bates S. Strategies for reversing drug resistance. Oncogene 22 (2003) 7512-7523
11. Sikic B.I., Fisher G.A., Lum B.L., Halsey J., Beketic-Oreskovic L., and Chen G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol. 40 Suppl. (1997) S13-S19
12. Tan B.J.M., Piwnica-Worms D., and Ratner L. Multidrug resistance transporters and modulation. Curr. Opin. Oncol. 12 (2000) 450-458
13. Fu L.W., Zhang Y.M., Liang Y.J., Yang X.P., et al. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinomaMCF-7/adr cells. Eur. J. Cancer 38 (2002) 418-426
14. Fu L.W., Liang Y.J., Deng L., Ding Y., et al. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemther. Pharmocol. 53 (2004) 349-356
15. Chen L.M., Wu X.P., Ruan J.W., Liang Y.J., et al. Screening novel potent multidrug-resistant modulators from imidazole derivatives. Oncol. Res. 14 (2004) 355-362
16. Chen L.M., Liang Y.J., Ruan J.W., Ding Y., et al. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. J. Pharm. Pharmacol. 56 (2004) 1061-1066
17. Nagayama S., Chen Z.S., Kitazono M., et al. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist ONO-1078. Cancer Lett. 130 (1998) 175-182
18. Okumura H., Chen Z.S., Sakou M., Sumizawa T., Furukawa T., Komatsu M., Ikeda R., Suzuki H., Hirota K., Aikou T., and Akiyama S.I. Reversal of P-glycoprotein and multidrug resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine K. Mol. Pharmacol. 58 (2000) 563-569
19. Aoki S., Chen Z.S., Higashiyama K., Setiawan A., Akiyama S., and Kobayashi M. Reversal effect of agosterol A, a spongean sterol acetate, on multidrug resistance in human carcinoma cells. Jpn. J. Cancer Res. 92 (2001) 886-895
20. Keller R.P., Altermatt H.J., Nooter K., Poschmann G., et al. SDZ PSC833, a non immunosuppressive cyclosporine: its potency in overcoming P-glycolprotein-mediated multidrug resistance of murine leukemia. Int. J. Cancer 50 (1992) 593-597
21. Shoji H., Tsuchida K., Kishi H., Yamakawa N., Matsuzaki T., Liu Z., Nakamura T., and Sugino H. Identification and characterization of a PDZ protein that interacts with activin type II receptors. J. Biol. Chem. 275 (2000) 5485-5492
22. Wang C.C., Wu C.H., Hsieh K.J., et al. Cytotoxic effects of cantharidin on the growth of normal carcinoma cells. J. Toxicol. 147 (2000) 77-87
23. Gerlach J.H., Kartner N., Bell D.R., and Ling V. Cancer Surv. 5 (1986) 23-45
24. Beck W.T. Pharmacology 36 (1987) 2879-2887
25. Shi Z., Liang Y.J., Chen Z.S., Wang X.W., et al. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol. Ther. 5 (2006) 39-47
26. Young R.C., Ozols R.F., and Myers C.E. The anthracycline antineoplastic drugs. N. Engl. J. Med. 305 (1981) 139-153
27. Bonness K., Aragon I.V., Rutland B., et al. Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2AA. Mol. Cancer Ther. 5 (2006) 2727-2737
28. Hu Y.P., Pourquier P., Doignon F., Crouzet M., and Robert J. Effects of modulators of multidrug resistance on the expression of the MDR1 gene in human KB cells in culture. Anticancer Drugs 7 (1996) 738-744